Researchers John F. Thompson and Gabrielle J. Williams discuss the timing of treatment for melanoma, emphasizing the importance of identifying high-risk patients early. They explore the implications of offering adjuvant therapy to patients whose melanoma may have already metastasized for better treatment outcomes.